Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.

Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Apr 2007

Matsueda Satoko, Takedatsu Hiroko, Sasada Tetsuro, Azuma Koichi, Ishihara Yuki, Komohara Yoshihiro, Noguchi Masanori, Shichijo Shigeki, Itoh Kyogo, Harada Mamoru

Abstract excerpt

We previously identified 2 cancer-associated antigens, immediate early response gene X-1 (IEX) and small GTPase (Ran), and their 5 epitopes using human leukocyte antigen (HLA)-A33-restricted and tumor-infiltrating T cells from a colon cancer patient. In this study, we examined whether or not these peptides can induce cytotoxic T lymphocytes (CTLs) in HLA-A11+ or HLA-A31+ epithelial cancer patients because the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Blocking
Share to Apoptosis Regulatory Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Vaccines

Share to HLA-A11 Antigen

Share to HLA-A3 Antigen

Share to ran GTP-Binding Protein

Share to T-Lymphocytes, Cytotoxic

Share to Vaccines, Subunit

Source

Identifiers

PMID: 17414318
DOI: 10.1097/01.cji.0000211340.88835.e7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.PMID 17414318Read ↗

Identification of peptide vaccine candidates sharing among HLA-A3+, -A11+, -A31+, and -A33+ cancer patients.Semantic proximity Read ↗

Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.Semantic proximity Read ↗

New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles.Semantic proximity Read ↗

Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele.Semantic proximity Read ↗

Detection of a set of peptide vaccine candidates for use in HLA-A31+ epithelial cancer patients.Semantic proximity Read ↗

An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.Semantic proximity Read ↗

Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.Semantic proximity Read ↗

CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.Semantic proximity Read ↗

Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancer.Semantic proximity Read ↗

Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.Semantic proximity Read ↗

Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood.Semantic proximity Read ↗

Identification of HLA‑A*1101‑restricted cytotoxic T lymphocyte epitopes derived from epidermal growth factor pathway substrate number 8.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.